Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis - No Study Results Posted

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis (DEFINE)

This study has been completed.

Study NCT00420212 Information provided by Biogen Idec

First Received: January 8, 2007 Last Updated: May 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2011
Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)